Skip to main content
Show — Main navigation
Hide — Main navigation
Submit an Article
Managing Interventional Oncology in the time of COVID-19
April 07, 2020
Don't miss this special live presentation on Managing Interventional Oncology in the Time of COVID-19, featuring insight by #CIO2020 Course Director, Edward Kim, MD.
Can Genomic Profiling Predict Radioembolization Outcomes in Patients with Metastatic Breast Cancer?
August 25, 2018
A recent study looked at the potential effectiveness of genomic profiling into predicting radioembolization outcome in patients with breast cancer metastatic to the liver with PI3K pathway mutation.
Radiofrequency Ablation vs Stereotactic Body Radiotherapy in NSCLC
August 19, 2018
A new study compared overall survival for patients with early-stage non–small cell lung cancer treated with either radiofrequency ablation or stereotactic body radiotherapy.
The Benefit of Radiofrequency Ablation in Patients With Comorbidities
August 14, 2018
Patients with small renal masses who are poor candidates for nephron-sparing surgery may benefit from radiofrequency ablation performed percutaneously.
Does Biopsy of Renal Masses Obviate the Need for Thermal Ablation?
August 14, 2018
Results of a retrospective review found that biopsy results of renal masses rarely obviated the need for subsequent ablation and can safely be performed alongside image-guided tumor ablation.
Liver Resection Versus TACE in Barcelona Clinic Liver Cancer Stage B HCC
August 07, 2018
Liver resection was found to have significant survival benefits over TACE in patients with Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.
Comparing Preoperative Strategies for Increasing Resectability in HCC
July 31, 2018
In a recent systemic review and meta-analysis, researchers evaluated preoperative strategies for their ability to effectively increase resectability rates in HCC.
Can Software Accurately Estimate Embolic Area in cTACE?
July 26, 2018
A commercially available 3-dimensional (3D) workstation and liver analysis software can be useful for estimating the embolic area in conventional transarterial chemoembolization for hepatocellular carcinoma.
Thermal Ablation vs Nephrectomy for Renal Cell Carcinoma
July 24, 2018
A recent study compared outcomes for thermal ablation versus nephrectomy for renal cell carcinoma.
Who Are the Super Survivors of Y-90 Treatment?
July 17, 2018
Some patients with unresectable hepatocellular carcinoma (HCC) have prolonged survival after treatment with yttrium-90 radioembolization.
Radioembolization Is Safe and Efficacious for Treatment of Unresectable Intrahepatic Cholangiocarcinoma
July 11, 2018
The study assessed whether patients with unresectable ICC can benefit from transarterial Y-90 glass microsphere radioembolization.
Back to Top